(E)-ferulic acid-d3 is the deuterated form of (E)-ferulic acid. (E)-ferulic acid is the body of ferulic acid (ferulic acid), an aromatic compound found in plant cell walls. (E)-ferulic acid causes the release of β-catenin Phosphorylation, leading to collagen degradation, increases the expression of the growth factor Bax and promotes the expression of growth factors and subsequent proteins. (E)-ferulic acid can effectively remove reactive oxygen species (ROS) and inhibit and regulate peroxidation. (E)-ferulic acid exerts antiproliferation and anti-migratory effects in human lung cancer cell line H1299.

Physicochemical Properties

Molecular Formula	C10H7D3O4
Molecular Weight	197.202
Exact Mass	197.077
CAS #	860605-59-0
Related CAS #	(E)-Ferulic acid;537-98-4
PubChem CID	45039253
Appearance	White to off-white solid powder
LogP	1.498
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	3
Heavy Atom Count	14
Complexity	224
Defined Atom Stereocenter Count	0
SMILES	[2H]C([2H])([2H])OC1=C(C=CC(=C1)/C=C/C(=O)O)O
InChi Key	KSEBMYQBYZTDHS-CGLOQUBRSA-N
InChi Code	InChI=1S/C10H10O4/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13)/b5-3+/i1D3
Chemical Name	(E)-3-[4-hydroxy-3-(trideuteriomethoxy)phenyl]prop-2-enoic acid
HS Tariff Code	2934.99.9001
Storage	Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Shipping Condition	Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity

ln Vitro	Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
References	[1]. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instability. Chin Med. 2016 Oct 1;11:45.

Solubility Data

Solubility (In Vitro)

DMSO : ~50 mg/mL (~253.55 mM)

Solubility (In Vivo)

Solubility in Formulation 1: ≥ 1.25 mg/mL (6.34 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.25 mg/mL (6.34 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 1.25 mg/mL (6.34 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.)

Preparing Stock Solutions		1 mg	5 mg	10 mg
	1 mM	5.0710 mL	25.3550 mL	50.7099 mL
	5 mM	1.0142 mL	5.0710 mL	10.1420 mL
	10 mM	0.5071 mL	2.5355 mL	5.0710 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.